For help on how to get the results you want, see our search tips.
161 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
Date of authorisation: 08/05/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
Date of authorisation: 18/10/2009,, Revision: 9, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii (updated)
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , , Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
Date of authorisation: 18/10/2013,, , , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Lenvima (updated)
Date of authorisation: 28/05/2015,, 
, Revision: 10, Authorised, Last updated: 15/11/2019
-
List item
Human medicine European public assessment report (EPAR): Empliciti (updated)
Date of authorisation: 11/05/2016,, , Revision: 6, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
Date of authorisation: 14/01/2015,, , Revision: 17, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kalydeco (updated)
Date of authorisation: 22/07/2012,, , Revision: 20, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Viekirax (updated)
Date of authorisation: 14/01/2015,, , Revision: 19, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Zynteglo (updated)
Date of authorisation: 29/05/2019,, , , 
, Revision: 1, Authorised, Last updated: 14/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vosevi (updated)
Date of authorisation: 26/07/2017,, , Revision: 6, Authorised, Last updated: 13/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kisplyx (updated)
Date of authorisation: 25/08/2016,, , Revision: 10, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Cabometyx
Date of authorisation: 09/09/2016,, , Revision: 6, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vpriv
Date of authorisation: 26/08/2010,, , Revision: 12, Authorised, Last updated: 07/11/2019
-
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
Date of authorisation: 10/10/2009,, Revision: 10, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Sovaldi
Date of authorisation: 16/01/2014,, , Revision: 19, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Epclusa
Date of authorisation: 06/07/2016,, , Revision: 10, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Harvoni
Date of authorisation: 17/11/2014,, , Revision: 18, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Soliris
Date of authorisation: 20/06/2007,, , Revision: 27, Authorised, Last updated: 30/10/2019